437 related articles for article (PubMed ID: 21909359)
1. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease.
Biron KE; Dickstein DL; Gopaul R; Jefferies WA
PLoS One; 2011; 6(8):e23789. PubMed ID: 21909359
[TBL] [Abstract][Full Text] [Related]
2. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
3. Cessation of neoangiogenesis in Alzheimer's disease follows amyloid-beta immunization.
Biron KE; Dickstein DL; Gopaul R; Fenninger F; Jefferies WA
Sci Rep; 2013; 3():1354. PubMed ID: 23446889
[TBL] [Abstract][Full Text] [Related]
4. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
5. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
[TBL] [Abstract][Full Text] [Related]
7. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
Hartz AM; Bauer B; Soldner EL; Wolf A; Boy S; Backhaus R; Mihaljevic I; Bogdahn U; Klünemann HH; Schuierer G; Schlachetzki F
Stroke; 2012 Feb; 43(2):514-23. PubMed ID: 22116809
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy.
Carrano A; Hoozemans JJ; van der Vies SM; van Horssen J; de Vries HE; Rozemuller AJ
Neurodegener Dis; 2012; 10(1-4):329-31. PubMed ID: 22301467
[TBL] [Abstract][Full Text] [Related]
10. Evidence of angiogenic vessels in Alzheimer's disease.
Desai BS; Schneider JA; Li JL; Carvey PM; Hendey B
J Neural Transm (Vienna); 2009 May; 116(5):587-97. PubMed ID: 19370387
[TBL] [Abstract][Full Text] [Related]
11. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
Kamat PK; Kyles P; Kalani A; Tyagi N
Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine potentiates amyloid
Carey A; Parodi-Rullan R; Vazquez-Torres R; Canepa E; Fossati S
Aging Cell; 2024 May; 23(5):e14106. PubMed ID: 38358083
[TBL] [Abstract][Full Text] [Related]
15. The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.
Wan W; Chen H; Li Y
Int J Neurosci; 2014 Feb; 124(2):75-81. PubMed ID: 23855502
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
Yang H; Wang W; Jia L; Qin W; Hou T; Wu Q; Li H; Tian Y; Jia J
J Alzheimers Dis; 2020; 74(1):261-275. PubMed ID: 32007956
[TBL] [Abstract][Full Text] [Related]
17. Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer's Disease.
Polis B; Gurevich V; Assa M; Samson AO
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540372
[TBL] [Abstract][Full Text] [Related]
18. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease.
Wisniewski HM; Vorbrodt AW; Wegiel J
Ann N Y Acad Sci; 1997 Sep; 826():161-72. PubMed ID: 9329688
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V
Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469
[TBL] [Abstract][Full Text] [Related]
20. Annexin A1 restores Aβ
Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
